Business Standard

GSK to offload HUL stake worth Rs 26,000 cr in largest secondary sale

Over 133 million shares, or 5.7% of the paid-up capital, are being offered for Rs 1,850-1,950 to investors through a special block window

Hindustan Unilever, HUL
Premium

The transaction is the largest secondary share sale in the domestic market, surpassing the previous Daiichi Sankyo’s $3.2 billion stake sale in Sun Pharmaceutical in 2015

Samie ModakShreepad Aute Mumbai
UK-based Glaxo-SmithKline (GSK) will offload shares worth Rs 26,000 crore in FMGC major Hindustan Unilever (HUL) on Thursday.

Over 133 million shares — 5.7 per cent of the total equity shares — are being offered in the range of Rs 1,850-1,950 to investors through a special block window, according to the term sheet reviewed by Business Standard.

Shares of HUL closed at Rs 2,002 on Wednesday, down 1.9 per cent on the NSE. In the past fortnight, shares have declined 16 per cent on account of the share sale overhang, coupled with the earnings disappointment. The benchmark Nifty has remained

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in